Jinfang Pharmaceutical-B (02595): As of September 18, a total of 872,000 H shares had been repurchased

Zhitongcaijing · 3d ago

According to Zhitong Finance App, Jingfang Pharmaceutical-B (02595) announced that as of September 18, 2026, the company has carried out a series of H share repurchases at the Hong Kong Stock Exchange Limited. A total of 872,000 H shares have been repurchased, accounting for about 0.227% of the company's total issued share capital as of the date of this announcement. The company may evaluate market conditions and continue to implement its 2026 H share repurchase plan.